Pulmonary primary oxysterol and bile acid synthesis as a predictor of outcomes in pulmonary arterial hypertension is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2024). On theSindex it has a DataRank of 0.269. It has been cited 5 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.269
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: 5R01HL160941-04
Risk stratification in pulmonary arterial hypertension: Intersection of OMICs and longitudinal phenotypes through the PAH Biobank
French National Research Agency (ANR)
Grant: ANR-21-CE44-0036
UBTD1: an ubiquitin scaffold protein at the cross roads of cell mechanics and cell metabolism
National Institutes of Health
Grant: 5R01HL124021-09
An endothelial-fibroblast axis connecting senescence to amino acid metabolism for control of vascular stiffness in PAH
National Institutes of Health
Grant: 4R24HL105333-05
National Biological Sample and Data Repository for PAH
National Institutes of Health
Grant: 2R01HL131532-06A1
Cardiac microstructure and the immune-inflammatory response to SARS-CoV-2
National Institutes of Health
Grant: 5R01HL143227-03
Mediators of Systemic Inflammation and Heart Failure Risk in the Community
National Institutes of Health
Grant: 5R01HL151828-03
Vaccine Induced Immune-Inflammatory Response and Cardiovascular Risk
National Institutes of Health
Grant: 7R01HL134168-04
Inflammatory Mediators, Cardiovascular Health, and Longevity in Women
Institut National du Cancer
Grant: unidentified
unidentified
National Institutes of Health
Grant: 5R01HL122596-04
Iron-Sulfur Deficiency as a Critical Pathogenic Cause of Pulmonary Hypertension
French National Research Agency (ANR)
Grant: ANR-20-CE14-0006
To capitalize on activated adventitial fibroblasts metabolism to treat pulmonary hypertension
National Institutes of Health
Grant: 3U54AG065141-05S1
The Microvascular Aging and Eicosanoids - Women's Evaluation of Systemic Aging Tenacity (MAE-WEST) ("You are never too old to become younger!") Specialized Center for Research Excellence (SCORE)
National Institutes of Health
Grant: 5F30HL143879-04
HIV-infected Macrophages Induce Endothelial Cell Dysfunction and Metabolic Reprogramming to Promote HIV-associated Pulmonary Arterial Hypertension
French National Research Agency (ANR)
Grant: ANR-18-CE14-0025
Understanding the dynamic of the vascular niche in pulmonary hypertension (PH). Matrix reprogramming forces PH.
National Institutes of Health
Grant: 5R01HL142983-03
Ventricular-vascular coupling in the elderly: lifecourse determinants, trajectories and prognostic significance
Fields of Study
Keywords
Sustainable Development Goals